Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 20/20 | 0.75 |
| ▸ | CA9 | Q16790 | 16/20 | 0.75 |
| ▸ | CA1 | P00915 | 19/20 | 0.61 |
| ▸ | CA12 | O43570 | 5/20 | 0.58 |
| ▸ | CA7 | P43166 | 5/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.58 |
| ▸ | CA3 | P07451 | 4/20 | 0.58 |
| ▸ | CA4 | P22748 | 4/20 | 0.58 |
| ▸ | CA6 | P23280 | 4/20 | 0.58 |
| ▸ | CA5A | P35218 | 4/20 | 0.58 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17365158 | 0.86 | — | — | |
| SCHEMBL6621065 | 0.77 | ALDH1A1 (0.61) | CA2CA9CA1CA12CA7 | |
| SCHEMBL5571140 | 0.77 | CA2 (0.45) | CA2CA9CA1CA12CA7 | |
| SCHEMBL786527 | 0.77 | CA2 (0.45) | CA2CA9CA1 | |
| SCHEMBL11593779 | 0.77 | CA2 (0.88) | CA2CA9CA1CA12CA7 | |
| SCHEMBL11593067 | 0.77 | CA1 (1.00) | CA2CA9CA1CA12CA7 | |
| SCHEMBL6406658 | 0.76 | CA2 (0.43) | CA2CA9CA1 | |
| SCHEMBL3477178 | 0.76 | TSHR (0.50) | CA2CA9CA1CA12CA7 | |
| SCHEMBL10352171 | 0.75 | CA1 (1.00) | CA2CA9CA1CA12CA7 | |
| SCHEMBL11592269 | 0.75 | CA1 (1.00) | CA2CA9CA1CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9770711-B2 | General catalyst for C-H functionalization | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2017-09-26 | — | — | US | disclosed |
| US-9770711-B2 | General catalyst for C-H functionalization | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2017-09-26 | — | — | US | disclosed |
| US-9770711-B2 | General catalyst for C-H functionalization | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2017-09-26 | — | — | US | disclosed |
| US-20160272662-A1 | GENERAL CATALYST FOR C-H FUNCTIONALIZATION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2016-09-22 | — | — | US | disclosed |
| US-20160272662-A1 | GENERAL CATALYST FOR C-H FUNCTIONALIZATION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2016-09-22 | — | — | US | disclosed |
| US-20160272662-A1 | GENERAL CATALYST FOR C-H FUNCTIONALIZATION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2016-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160272662-A1 | GENERAL CATALYST FOR C-H FUNCTIONALIZATION | BET1, PLEC, NUDC | CA2 1192/4885CA9 517/4885CA1 555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.